Education
About Us
Working with TipRanks
Follow Us
Artivion Inc. (DE:CYL)
:CYL
CYL Stock Chart & Stats
Day’s Range― - ―
52-Week Range€18.10 - €30.75
Previous CloseN/A
Volume0.00
Average Volume (3M)72.00
Market Cap
€905.25M
Enterprise Value€1.42B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$8.12M
Price to Earnings (P/E)―
Beta0.95
Next Earnings
May 01, 2025EPS Estimate
-0.11Last Dividend Ex-Date
Dec 09, 2015Dividend YieldN/A
Share Statistics
EPS (TTM)-0.30
Shares Outstanding42,047,890
10 Day Avg. Volume65
30 Day Avg. Volume72
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.54
Price to Cash Flow (P/CF)24.40
P/FCF Ratio7.50
Enterprise Value/Market Cap1.57
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.71
Enterprise Value/Ebitda34.97
Forecast
1Y Price Target
€29.71Price Target Upside30.30% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
---
Artivion News
PremiumCompany Announcements
Artivion Inc. Reports Strong 2024 Earnings Amid Challenges
---
Bulls Say, Bears Say
Bulls Say
Market ExpansionExpectations for AORT to receive a premarket approval could expand its market coverage, representing a significant annual US market opportunity.
Regulatory ApprovalsThe earlier-than-expected approval of the AMDS humanitarian-device-exemption is anticipated to positively contribute to 2025 top-line growth.
Revenue GrowthDespite the cybersecurity attack, Artivion is now operating near full capacity and expects significant revenue growth in the year.
Bears Say
Cybersecurity ImpactThe December cybersecurity breach led to lower-than-expected 4Q24 sales, impacting the company's financial performance.
Price Target AdjustmentThe price target was lowered to $32 from $34, given the cybersecurity issue.
Revenue ForecastThe cyber incident is expected to continue affecting the company's performance in the immediate future, with management projecting lower 1Q25 revenues compared to previous estimates.
---
Options Prices
Currently, No data available
---
Ownership Overview
4.78% Insiders
26.39% Mutual Funds
26.40% Other Institutional Investors
20.29% Public Companies and Individual Investors
CYL FAQ
What was Artivion Inc.’s price range in the past 12 months?
Artivion Inc. lowest stock price was €18.10 and its highest was €30.75 in the past 12 months.
What is Artivion Inc.’s market cap?
Artivion Inc.’s market cap is €905.25M.
When is Artivion Inc.’s upcoming earnings report date?
Artivion Inc.’s upcoming earnings report date is May 01, 2025 which is in 50 days.
How were Artivion Inc.’s earnings last quarter?
Artivion Inc. released its earnings results on Feb 24, 2025. The company reported -€0.374 earnings per share for the quarter, missing the consensus estimate of -€0.062 by -€0.312.
Is Artivion Inc. overvalued?
According to Wall Street analysts Artivion Inc.’s price is currently Undervalued.
Does Artivion Inc. pay dividends?
Artivion Inc. pays a Quarterly dividend of €0.028 which represents an annual dividend yield of N/A. See more information on Artivion Inc. dividends here
What is Artivion Inc.’s EPS estimate?
Artivion Inc.’s EPS estimate is -0.11.
How many shares outstanding does Artivion Inc. have?
Artivion Inc. has 42,047,890 shares outstanding.
What happened to Artivion Inc.’s price movement after its last earnings report?
Artivion Inc. reported an EPS of -€0.374 in its last earnings report, missing expectations of -€0.062. Following the earnings report the stock price went down -5.421%.
Which hedge fund is a major shareholder of Artivion Inc.?
Currently, no hedge funds are holding shares in DE:CYL
---
Artivion Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€29.71 (30.30% Upside)
€29.71 (30.30% Upside)
Blogger Sentiment
Bullish
DE:CYL Sentiment 70%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $2.3M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
17.93%
12-Months-Change
Fundamentals
Return on Equity
-4.78%
Trailing 12-Months
Asset Growth
-0.42%
Trailing 12-Months
Company Description
Artivion Inc.
CryoLife, Inc. engages in the manufacture, process and distribution of medical devices. It operates through the following segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of BioGlue; JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PerClot and PhotoFix. The Preservation Services segment focuses on external services revenues from the preservation of cardiac and vascular tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.
---
CYL Company Deck
---
CYL Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a strong financial performance for 2024, with impressive revenue and EBITDA growth and successful product approvals. However, the company faced challenges due to a cybersecurity incident that impacted Q4 results and led to delays in product processing and PMA approval for AMDS. Despite these setbacks, the positive developments in product approvals and international growth suggest optimism for 2025.Read More>---
CYL Stock 12 Month Forecast
Average Price Target
€29.71
▲(30.30% Upside)
Technical Analysis
Best Analysts Covering CYL
1 Year
1 Year Success Rate
19/35 ratings generated profit
1 Year Average Return
+10.48%
reiterated a buy rating last month
Copying Suraj Kalia's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +10.48% per trade.
---